Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX), a diagnostic information services leader, has announced that Chairman, CEO and President Jim Davis will participate in the Baird 2025 Global Healthcare Conference. The presentation will take place on September 10, 2025, at 10:50 a.m. Eastern Time in New York City.
The event will feature a fireside chat and Q&A session focusing on Quest's strategy, performance, and market trends. Investors can access the live webcast through Quest's investor relations website at ir.QuestDiagnostics.com. The archived webcast will be available within 24 hours after the event and remain accessible until October 3, 2025.
Positive
- None.
Negative
- None.
The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 3, 2025.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-baird-2025-global-healthcare-conference-302531411.html
SOURCE Quest Diagnostics